Monopar Therapeutics Inc (MNPR)

11:03 AM

Monopar Therapeutics (NASDAQ:MNPR) Earns Buy Rating from BTIG Research - MarketBeat

11:03 AM

08:52 AM

Promising Long-Term Efficacy and Safety of ALXN1840 Strengthens Buy Rating for Monopar Therapeutics Inc. - TipRanks

08:52 AM

02:59 AM

Analyzing Monopar Therapeutics Inc. with risk reward ratio chartsMarket Weekly Review & Safe Entry Momentum Tips - newser.com

02:59 AM

02:25 AM

How to integrate Monopar Therapeutics Inc. into portfolio analysis toolsRecession Risk & Fast Moving Stock Watchlists - newser.com

02:25 AM

12:35 PM

Historical volatility pattern of Monopar Therapeutics Inc. visualizedTake Profit & Risk Controlled Daily Trade Plans - newser.com

12:35 PM

Sep 15, 2025

Bull Bear: Will Monopar Therapeutics Inc benefit from green energy policiesMarket Risk Report & Safe Swing Trade Setup Alerts - خودرو بانک

Sep 15, 2025

Sep 15, 2025

Monopar Therapeutics Presents New Data on ALXN1840 - TipRanks

Sep 15, 2025

Sep 15, 2025

Bull Run: Is Monopar Therapeutics Inc impacted by rising rates2025 Analyst Calls & Risk Controlled Daily Plans - خودرو بانک

Sep 15, 2025

Sep 15, 2025

Monopar Therapeutics, A Top 1% Biotech Stock, Just Surged Into A Breakout. Here's Why. - Investor's Business Daily

Sep 15, 2025

Sep 15, 2025

Why Monopar Therapeutics, A Top 1% Biotech Stock, Just Surged Into A Breakout - inkl

Sep 15, 2025

Sep 15, 2025

BTIG Reiterates Buy Rating on MNPR with $87 Price Target | MNPR Stock News - GuruFocus

Sep 15, 2025

Sep 15, 2025

Analyzing recovery setups for Monopar Therapeutics Inc. investorsBond Market & Safe Capital Investment Plans - newser.com

Sep 15, 2025

Sep 15, 2025

H.C. Wainwright Maintains Monopar Therapeutics(MNPR.US) With Buy Rating, Maintains Target Price $70 - 富途牛牛

Sep 15, 2025

Sep 15, 2025

Monopar Therapeutics Inc’s ALXN1840: A Promising Breakthrough in Wilson Disease Treatment Justifying Buy Rating - TipRanks

Sep 15, 2025

Sep 15, 2025

Can trapped investors hope for a rebound in Monopar Therapeutics Inc.Weekly Risk Report & Weekly Top Gainers Trade List - newser.com

Sep 15, 2025

Sep 15, 2025

Can volume confirm reversal in Monopar Therapeutics Inc.Weekly Market Outlook & Intraday High Probability Setup Alerts - newser.com

Sep 15, 2025

Sep 15, 2025

Risk Report: Will Monopar Therapeutics Inc outperform small cap indexesWeekly Investment Recap & AI Driven Price Forecasts - خودرو بانک

Sep 15, 2025

Sep 15, 2025

Monopar Therapeutics (NASDAQ:MNPR) Now Covered by BTIG Research - MarketBeat

Sep 15, 2025

Sep 14, 2025

Monopar Therapeutics (MNPR) to Present Promising Wilson Disease Therapy Data - GuruFocus

Sep 14, 2025

Sep 14, 2025

Full technical analysis of Monopar Therapeutics Inc. stockWeekly Market Outlook & Smart Investment Allocation Tips - newser.com

Sep 14, 2025

Sep 14, 2025

Is Monopar Therapeutics Inc. stock ready for a breakoutJuly 2025 Action & High Accuracy Trade Signal Alerts - newser.com

Sep 14, 2025

Sep 14, 2025

Understanding Monopar Therapeutics Inc.’s price movementWall Street Watch & Low Drawdown Investment Ideas - newser.com

Sep 14, 2025

Sep 14, 2025

Monopar to Present New Long-Term Neurological Efficacy and Safety Data for ALXN1840 in Wilson Disease at the 150th American Neurological Association Annual Meeting - The Manila Times

Sep 14, 2025

Sep 14, 2025

Monopar Therapeutics Presents Promising Long-Term Data on ALXN1840 for Wilson Disease at ANA Annual Meeting - Quiver Quantitative

Sep 14, 2025

Sep 14, 2025

6 Years of Sustained Brain Function Improvement: Monopar's Wilson Disease Drug Shows Breakthrough Results - Stock Titan

Sep 14, 2025

Sep 14, 2025

What MACD and RSI say about Monopar Therapeutics Inc.CEO Change & Low Risk High Win Rate Picks - newser.com

Sep 14, 2025

Sep 12, 2025

What MACD signals say about Monopar Therapeutics Inc.Gap Down & Risk Adjusted Buy and Sell Alerts - Newser

Sep 12, 2025

Sep 12, 2025

will monopar therapeutics inc. bounce back from current supportMarket Risk Summary & Long-Term Capital Growth Ideas - Newser

Sep 12, 2025

Sep 12, 2025

Analyzing net buyer seller activity in Monopar Therapeutics Inc.Portfolio Risk Summary & Pattern Based Trade Signal System - Newser

Sep 12, 2025

Sep 12, 2025

Detecting support and resistance levels for Monopar Therapeutics Inc.Gold Moves & Detailed Earnings Play Alerts - Newser

Sep 12, 2025

Sep 12, 2025

Evaluating Monopar Therapeutics Inc. with trendline analysisBond Market & Stepwise Entry/Exit Trade Alerts - Newser

Sep 12, 2025

Sep 12, 2025

Using data models to predict Monopar Therapeutics Inc. stock movementJuly 2025 PostEarnings & Real-Time Volume Analysis - Newser

Sep 12, 2025

Sep 12, 2025

Momentum divergence signals in Monopar Therapeutics Inc. chartJuly 2025 Review & Free Technical Pattern Based Buy Signals - Newser

Sep 12, 2025

Sep 12, 2025

Is now a turning point for Monopar Therapeutics Inc.2025 Valuation Update & Long-Term Growth Stock Strategies - Newser

Sep 12, 2025

Sep 11, 2025

Can machine learning forecast Monopar Therapeutics Inc. recovery2025 Top Gainers & Step-by-Step Trade Execution Guides - Newser

Sep 11, 2025

Sep 11, 2025

Monopar Therapeutics Inc. (NASDAQ:MNPR) Receives Average Recommendation of "Buy" from Brokerages - MarketBeat

Sep 11, 2025